title: Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections.
abstract: Prevention of bacterial colonization and formation of a bacterial biofilm on implant surfaces has been a challenge in orthopaedic surgery. The treatment of implant-associated infections with conventional antibiotics has become more complicated by the emergence of multi-drug resistant bacteria. Antimicrobial eluting coatings on implants is one of the most promising strategies that have been attempted. This study reports a controlled release of an antimicrobial peptide (AMP) from titanium surface through a non-cytotoxic multilayered coating. Three layers of vertically oriented TiO2 nanotubes, a thin layer of calcium phosphate coating and a phospholipid (POPC) film were impregnated with a potent broad-spectrum AMP (HHC-36). The coating with controlled and sustained release of AMP was highly effective against both Gram-positive (Staphylococcus aureus) and Gram-negative (Pseudomonas aeruginosa) bacteria. No cytotoxicity to osteoblast-like cells (MG-63) was observed. Moderate platelet activation and adhesion on the implant surface with no observable activation in solution, and very low red blood cell lysis was observed on the implant. This multi-layer assembly can be a potential approach to locally deliver AMPs to prevent peri-implant infection in orthopaedics without being toxic to host cells.
authors.affiliation: Department of Materials Engineering, University of British Columbia, Vancouver, Canada.
authors.forename: Mehdi
authors.initials: M
authors.lastname: Kazemzadeh-Narbat
authors.forename: Benjamin F L
authors.initials: BF
authors.lastname: Lai
authors.forename: Chuanfan
authors.initials: C
authors.lastname: Ding
authors.forename: Jayachandran N
authors.initials: JN
authors.lastname: Kizhakkedathu
authors.forename: Robert E W
authors.initials: RE
authors.lastname: Hancock
authors.forename: Rizhi
authors.initials: R
authors.lastname: Wang
mesh_terms: D000595:Amino Acid Sequence; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002130:Calcium Phosphates / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects; D016923:Cell Death / Q000187:drug effects; D002460:Cell Line; D020099:Coated Materials, Biocompatible / Q000494:pharmacology*; D003692:Delayed-Action Preparations; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D020007:Implants, Experimental; D007700:Kinetics; D008422:Materials Testing; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D043942:Nanotubes / Q000648:ultrastructure; D010743:Phospholipids / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000648:ultrastructure; D017550:Spectroscopy, Fourier Transform Infrared; D013211:Staphylococcus aureus / Q000187:drug effects / Q000648:ultrastructure; D014025:Titanium / Q000494:pharmacology*
chemical_list: D023181:Antimicrobial Cationic Peptides; D002130:Calcium Phosphates; D020099:Coated Materials, Biocompatible; D003692:Delayed-Action Preparations; D010743:Phospholipids; C020243:calcium phosphate; D014025:Titanium